In summary, the present study reported a TfR1 and CPPs dual-targeted probe for the noninvasive quantitative evaluation of the degree of MI/R-induced cardiac injury in vivo using the feMPI strategy. The gene discussed is TFRC; the disease is myocardial infarction.